HETEROBICYCLIC DERIVATIVES AS ITK INHIBITORS

AR135376A1Pending Publication Date: 2026-09-02ALMIRALL SA

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: ARP20250100563
Authority / Receiving Office: AR · AR
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2024-02-28
Filing Date: 2025-02-28
Publication Date: 2026-09-02

Application Information

Patent Timeline

28 Feb 2024

Priority

28 Feb 2025

Application

ARP20250100563

02 Sep 2026

Publication

AR135376A1

IPC: C07D487/04

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.

Claims

New heterobicyclic derivatives of formula (1) are described; as well as a process for their preparation, pharmaceutical compositions comprising them and their use in therapy as interleukin-2 inducible T cell kinase (ITK) inhibitors.